FEBS Letters · 2014 · 61 citations · 20 references
Life SciencesMolecular BiologyOncologyGene ExpressionMolecular OncologyTranscriptional RegulationCancer EpigeneticsChromatinEpigenetic Regulation In CancerHistone ProteinsPolycomb RegulationPromoter RegulationCancer Cell Proliferation InhibitionH3k27 TrimethylationPolycomb Group ProteinsPolycomb Group RegulationPolycomb Group RepressionPolycomb RepressionPolycomb-mediated Gene RepressionPolycomb-mediated Repression
EZH2 is a key component of the polycomb PRC2 complex and functions as a histone H3 Lys27 (H3K27) trimethyltransferase. Here we show that EZH2 is down-regulated in human non-small cell lung cancer and low EZH2 expression predicts poor survival. Further we demonstrate that EZH2 inhibits lung cancer cell proliferation and colony formation in vitro and growth in vivo. We found that EZH2 binds to the promoter of Nrf2, where it increases H3K27me3 and represses Nrf2 expression. Finally, Nrf2 seems to be essential for the hyper proliferation of lung cancer cells in the absence of EZH2.
20
The polycomb group protein EZH2 is involved in progression of prostate cancer
Sooryanarayana Varambally, Saravana M. Dhanasekaran, Ming Zhou et al. · Nature · 2002 · 2.7K citations · Full text
Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
Anju Singh, Vikas Misra, Rajesh K. Thimmulappa et al. · PLoS Medicine · 2006 · 1K citations · Full text
Ingeborg Bachmann, Ole J. Halvorsen, Karin Collett et al. · Journal of Clinical Oncology · 2005 · 844 citations